China Life Science and Technology Innovation Fund

elsewhere's corpus does not cover this subject. The only direct mention of China Life Science and Technology Innovation Fund (also referred to as 国寿科创基金 / 国寿科创基金) is a single co-investment record from 2023, where it followed the lead investors in Inming Biotech's 700 million RMB Series A round alongside Taiping Healthcare Fund and others . No founding date, size, strategy, or team details appear in the retrieved material.